Fulcrum Therapeutics (FULC) Common Equity (2018 - 2026)
Fulcrum Therapeutics (FULC) reported Common Equity of $310.7 million for Q2 2026, up 44.9% from $214.38 million a year earlier but down 6.8% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Fulcrum Therapeutics posted Common Equity of $349 million, up 43.6% from FY2024.
- Common Equity has increased for three consecutive years, with a five-year compound annual growth rate of 29.7% (FY2020 to FY2025).
- By year, Common Equity came in at $243.03 million in FY2024 (+3.3%), $235.19 million in FY2023 (+18.2%), $198.94 million in FY2022 (-6.0%) and $211.54 million in FY2021 (+122.2%).
- Five-year quarterly Common Equity spans a low of $160.76 million in Q2 2022 and a high of $349 million in Q4 2025.
- Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 12.6% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q4 2021 (growth of 122.2%); the low point was Q1 2024 (a decline of 27.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $333.3 million (Q1 2026), $349 million (Q4 2025) and $198.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Fulcrum Therapeutics | 283.78 Mn | 283.78 Mn | - | 310.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 310.70 Mn |
| Mar 31, 2026 | 333.30 Mn |
| Dec 31, 2025 | 349.00 Mn |
| Sep 30, 2025 | 198.37 Mn |
| Jun 30, 2025 | 214.38 Mn |
| Mar 31, 2025 | 228.49 Mn |
| Dec 31, 2024 | 243.03 Mn |
| Sep 30, 2024 | 257.29 Mn |
| Jun 30, 2024 | 273.79 Mn |
| Mar 31, 2024 | 213.59 Mn |
| Dec 31, 2023 | 235.19 Mn |
| Sep 30, 2023 | 255.46 Mn |
| Jun 30, 2023 | 275.43 Mn |
| Mar 31, 2023 | 296.26 Mn |
| Dec 31, 2022 | 198.94 Mn |
| Sep 30, 2022 | 221.41 Mn |
| Jun 30, 2022 | 160.76 Mn |
| Mar 31, 2022 | 189.16 Mn |
| Dec 31, 2021 | 211.54 Mn |
| Sep 30, 2021 | 230.61 Mn |
API Access
Fulcrum Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();